Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )

CompletedOBSERVATIONAL
Enrollment

2,475

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Post Thrombotic SyndromeVenous ThromboembolismCardiovascular Diseases
Interventions
OTHER

Villalta phone score > or = to 5

"Follow up call. At the end of the follow-up, the patients who received an Utne and Sandset Villalta phone score \> or = 5 will have a visit with clinical and CUS assessments of PTS/ venous insufficiency.~All patients will have self administered-questionnaires. For Grenoble Center, the 200 first patients with clinical follow-up will have an Echo-Doppler examination."

OTHER

Villalta phone score < 5

"Follow up call. At the end of the follow-up, the patients who received an Utne and Sandset Villalta phone score \< 5, will don't have a clinical follow up.~All patients will have self administered-questionnaires."

Trial Locations (1)

38043

CHU Grenoble Alpes, Grenoble

Sponsors
All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

collaborator

Ministry of Health, France

OTHER_GOV

collaborator

LEO Pharma

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

University Hospital, Grenoble

OTHER

lead

Association des Médecins Vasculaires Hospitaliers

OTHER